Global Plasma Protein Therapeutics Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5685814   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Plasma protein therapeutics refers to a category of medical treatments derived from human plasma proteins, which are isolated and purified to produce therapeutic products. These proteins play essential roles in various physiological processes, and when deficient or dysfunctional, they can lead to medical conditions. Plasma protein therapeutics include a range of products such as clotting factors for hemophilia, immunoglobulins for immune disorders, albumin for maintaining blood volume, and other proteins involved in coagulation and immune response. These therapies are typically administered through intravenous infusion to patients with congenital or acquired disorders affecting the production or function of specific proteins. Plasma protein therapeutics have revolutionized the treatment of various rare diseases, providing life-saving and life-sustaining interventions for individuals with conditions that were once challenging to manage effectively. The production of these therapeutics involves the plasma fractionation process, where plasma is separated into its constituent parts, and specific proteins are isolated and purified for therapeutic use.
According to DIResearch's in-depth investigation and research, the global Plasma Protein Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Plasma Protein Therapeutics include Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Plasma Protein Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Plasma Protein Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Plasma Protein Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Protein Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Plasma Protein Therapeutics Include:
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Plasma Protein Therapeutics Product Segment Include:
Coagulation Factor
Immune Globulin
Albumin
Others
Plasma Protein Therapeutics Product Application Include:
Hemophilia
Pelvic inflammatory disease (PID)
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Plasma Protein Therapeutics Industry PESTEL Analysis
Chapter 3: Global Plasma Protein Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Plasma Protein Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Plasma Protein Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Plasma Protein Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Plasma Protein Therapeutics Market Overview

1.1 Product Definition and Statistical Scope

1.2 Plasma Protein Therapeutics Product by Type

1.2.1 Global Plasma Protein Therapeutics Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Coagulation Factor

1.2.3 Immune Globulin

1.2.4 Albumin

1.2.5 Others

1.3 Plasma Protein Therapeutics Product by Application

1.3.1 Global Plasma Protein Therapeutics Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hemophilia

1.3.3 Pelvic inflammatory disease (PID)

1.3.4 Others

1.4 Global Plasma Protein Therapeutics Market Revenue Analysis (2019-2030)

1.5 Plasma Protein Therapeutics Market Development Status and Trends

1.5.1 Plasma Protein Therapeutics Industry Development Status Analysis

1.5.2 Plasma Protein Therapeutics Industry Development Trends Analysis

2 Plasma Protein Therapeutics Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Plasma Protein Therapeutics Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Plasma Protein Therapeutics Market Analysis by Regions

4.1 Plasma Protein Therapeutics Overall Market: 2023 VS 2024 VS 2030

4.2 Global Plasma Protein Therapeutics Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Plasma Protein Therapeutics Revenue and Market Share by Region (2019-2024)

4.2.2 Global Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030)

5 Global Plasma Protein Therapeutics Market Size by Type and Application

5.1 Global Plasma Protein Therapeutics Market Size by Type

5.2 Global Plasma Protein Therapeutics Market Size by Application

6 North America

6.1 North America Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Plasma Protein Therapeutics Market Size by Type

6.4 North America Plasma Protein Therapeutics Market Size by Application

6.5 North America Plasma Protein Therapeutics Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Plasma Protein Therapeutics Market Size by Type

7.4 Europe Plasma Protein Therapeutics Market Size by Application

7.5 Europe Plasma Protein Therapeutics Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Plasma Protein Therapeutics Market Size by Type

8.4 China Plasma Protein Therapeutics Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Plasma Protein Therapeutics Market Size by Type

9.4 APAC (excl. China) Plasma Protein Therapeutics Market Size by Application

9.5 APAC (excl. China) Plasma Protein Therapeutics Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Plasma Protein Therapeutics Market Size by Type

10.4 Latin America Plasma Protein Therapeutics Market Size by Application

10.5 Latin America Plasma Protein Therapeutics Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Plasma Protein Therapeutics Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Type

11.4 Middle East & Africa Plasma Protein Therapeutics Market Size by Application

11.5 Middle East & Africa Plasma Protein Therapeutics Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Plasma Protein Therapeutics Market Revenue by Key Manufacturers (2020-2024)

12.2 Plasma Protein Therapeutics Competitive Landscape Analysis and Market Dynamic

12.2.1 Plasma Protein Therapeutics Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Shire (Baxalta)

13.1.1 Shire (Baxalta) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio

13.1.3 Shire (Baxalta) Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 CSL

13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 CSL Plasma Protein Therapeutics Product Portfolio

13.2.3 CSL Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Grifols

13.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Grifols Plasma Protein Therapeutics Product Portfolio

13.3.3 Grifols Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Octapharma

13.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Octapharma Plasma Protein Therapeutics Product Portfolio

13.4.3 Octapharma Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Kedrion

13.5.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Kedrion Plasma Protein Therapeutics Product Portfolio

13.5.3 Kedrion Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 LFB Group

13.6.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 LFB Group Plasma Protein Therapeutics Product Portfolio

13.6.3 LFB Group Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Biotest

13.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Biotest Plasma Protein Therapeutics Product Portfolio

13.7.3 Biotest Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 BPL

13.8.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 BPL Plasma Protein Therapeutics Product Portfolio

13.8.3 BPL Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 RAAS

13.9.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 RAAS Plasma Protein Therapeutics Product Portfolio

13.9.3 RAAS Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 CBPO

13.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 CBPO Plasma Protein Therapeutics Product Portfolio

13.10.3 CBPO Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Hualan Bio

13.11.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Hualan Bio Plasma Protein Therapeutics Product Portfolio

13.11.3 Hualan Bio Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Kamada

13.12.1 Kamada Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Kamada Plasma Protein Therapeutics Product Portfolio

13.12.3 Kamada Plasma Protein Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Plasma Protein Therapeutics Industry Chain Analysis

14.2 Plasma Protein Therapeutics Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Plasma Protein Therapeutics Typical Downstream Customers

14.4 Plasma Protein Therapeutics Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support